Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
Our coverage here includes several modestly valued companies whose shares should recover strongly when the world re-opens for business. However, others may turn out to be classic value traps. Read on for our usual insightful comment.
James Halstead: another dividend increase
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on Anexo Group PLC
Focus on the cash flow
Results and updates from AIM companies covered here extend from the fast growers to…
Some welcome good news at last for shareholders in this provider of online competitions to win…
The share prices of companies in the UK building materials sector have sold off significantly over…
Results and updates from AIM, covered in our Blog here were overwhelmingly positive for a change, with…
A company covered here is set to do nicely from rising interest rates while another looks…
Updates covered here include a trading update from an unusual provider of alternative finance solutions, which comes…
The shares of technology stocks are plummeting, but that hasn’t stopped this AIM company paying what…
Results and updates covered here include those of several consistent (and highly-rated) performers, but a potential…
Our coverage here includes several modestly valued companies whose shares should recover strongly when the world…
Our Income Boosters portfolio is continuing to deliver reliable dividends in tough conditions. The companies in our income portfolio have delivered stable dividends against a weaker market backdrop. Find…
Yet another highly valued retail play, which only joined AIM a year ago, has seen its…
Results and updates covered here cover plenty of the mundane from the building materials sector and…
Results and updates covered here include yet more disappointment for shareholders of online wine retailer Naked…
Our coverage here includes several modestly valued companies whose shares should recover strongly when the world…
Our coverage here includes several modestly valued companies whose shares should recover strongly when the world…
Our portfolio has delivered twice the growth of the S&P 500 in the year to date.…
Better than expected
Building products day
Cheap as bricks
Beneficiary of rising interest rates
Where a 7% dividend yield hides a multitude of issues
Bonkers deal of the week or another nifty acquisition?
Strong updates to enjoy
Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
Income Boosters update: these yields look safe
Income Boosters - June ‘22 portfolio update
Another IPO from 2021 tumbles
Boring is often best, but then there is hydrogen!
Naked Wines: stripping shareholders bare
Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
US software stocks shine in lockdown
More Company Insights
Focus on the cash flow
Better than expected
Plenty of waffle
Dieselgate could deliver big returns for this company
Building products day
Cheap as bricks
Quality company delivers | Inflationary tales
Stunning results | Bonkers Bargain update | Hospitality recovery
Beneficiary of rising interest rates
Where a 7% dividend yield hides a multitude of issues
Orders, acquisitions and doubts
From the brilliant to the bonkers
Bonkers deal of the week or another nifty acquisition?
Strong updates to enjoy
Hydrogen potential here
Bonkers Bargain updates
Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
Income Boosters update: these yields look safe
Income Boosters - June ‘22 portfolio update
Income Boosters: soaring dividends
Income Boosters’ March quarter update
Another IPO from 2021 tumbles
Boring is often best, but then there is hydrogen!
Upgrades, Downgrades and everything in between
Impressive as ever
Naked Wines: stripping shareholders bare
Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
Vaccine countdown update: 10 Nov - positive results from some, cash flow concerns with others
Coronavirus impact: 14 July - plenty of updates and a bizarre response from Manolete
Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
US software stocks shine in lockdown
Coronavirus crash victims: is the only way up?
The essential, important and forgotten - reopening winners and losers
More Company Insights
Bonkers Bargains: a rare find indeed
AIM new arrivals and leavers September 2022
Horrendous updates
